320 related articles for article (PubMed ID: 16868972)
1. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
Harrison MJ; Ravdin LD; Lockshin MD
Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
[TBL] [Abstract][Full Text] [Related]
2. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
4. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.
Hanly JG; Hong C; Smith S; Fisk JD
Arthritis Rheum; 1999 Apr; 42(4):728-34. PubMed ID: 10211887
[TBL] [Abstract][Full Text] [Related]
5. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
Kozora E; Ellison MC; West S
Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786
[TBL] [Abstract][Full Text] [Related]
6. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
[TBL] [Abstract][Full Text] [Related]
8. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
[TBL] [Abstract][Full Text] [Related]
9. Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials.
; Mikdashi JA; Esdaile JM; Alarcón GS; Crofford L; Fessler BJ; Shanberg L; Brunner H; Gall V; Kalden JR; Lockshin MD; Liang MH; Roberts N; Schneider M
Lupus; 2007; 16(6):418-25. PubMed ID: 17664232
[TBL] [Abstract][Full Text] [Related]
10. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
11. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
[TBL] [Abstract][Full Text] [Related]
12. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus.
Denburg SD; Carbotte RM; Ginsberg JS; Denburg JA
J Int Neuropsychol Soc; 1997 Jul; 3(4):377-86. PubMed ID: 9260447
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus.
Menon S; Jameson-Shortall E; Newman SP; Hall-Craggs MR; Chinn R; Isenberg DA
Arthritis Rheum; 1999 Apr; 42(4):735-41. PubMed ID: 10211888
[TBL] [Abstract][Full Text] [Related]
14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
[TBL] [Abstract][Full Text] [Related]
16. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.
Utset TO; Fink J; Doninger NA
J Rheumatol; 2006 Mar; 33(3):531-8. PubMed ID: 16511923
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
Harboe E; Tjensvoll AB; Maroni S; Gøransson LG; Greve OJ; Beyer MK; Herigstad A; Kvaløy JT; Omdal R
Ann Rheum Dis; 2009 Oct; 68(10):1541-6. PubMed ID: 18930990
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction in systemic lupus erythematosus.
Emori A; Matsushima E; Aihara O; Ohta K; Koike R; Miyasaka N; Kato M
Psychiatry Clin Neurosci; 2005 Oct; 59(5):584-9. PubMed ID: 16194262
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of circulating anti-N-methyl-
Tay SH; Fairhurst AM; Mak A
Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
